Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Interventional 8 Observational 1

Sponsor

Cancer Type

Conditions

Interventions

Blood Specimen Collection 53 Surveys and Questionnaires 49 Specimen Handling 29 Observation 15 Radiotherapy 14 Magnetic Resonance Spectroscopy 12 Surgical Procedures, Operative 11 Interviews as Topic 11 Data Collection 11 Drug Therapy 9 darolutamide 8 Biopsy 8 palbociclib 7 Watchful Waiting 7 Tomography, X-Ray Computed 7 Standard of Care 7 ribociclib 6 Magnetic Resonance Imaging 6 Bevacizumab 6 trastuzumab deruxtecan 5 Ultrasonography 5 Restraint, Physical 5 Radiofrequency Ablation 5 Patient Reported Outcome Measures 5 Mental Status and Dementia Tests 5 Mastectomy, Segmental 5 Mass Screening 5 Genetic Testing 5 Breath Tests 5 enzalutamide 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Tirzepatide × 90 days × Clear all

NCT06485089 2026-05-28

Effects of Tirzepatide on Blood, Imaging and Breast Tissue Biomarkers

University of Kansas Medical Center

Obesity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡